Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Nanoparticle Classification Using Frequency Domain Analysis on Resource-Limited Platforms.

Yayla M, Toma A, Chen KH, Lenssen JE, Shpacovitch V, Hergenröder R, Weichert F, Chen JJ.

Sensors (Basel). 2019 Sep 24;19(19). pii: E4138. doi: 10.3390/s19194138.

2.

Optical and surface plasmonic approaches to characterize extracellular vesicles. A review.

Shpacovitch V, Hergenröder R.

Anal Chim Acta. 2018 Apr 16;1005:1-15. doi: 10.1016/j.aca.2017.11.066. Epub 2017 Dec 12. Review.

PMID:
29389314
3.

Application of the PAMONO-Sensor for Quantification of Microvesicles and Determination of Nano-Particle Size Distribution.

Shpacovitch V, Sidorenko I, Lenssen JE, Temchura V, Weichert F, Müller H, Überla K, Zybin A, Schramm A, Hergenröder R.

Sensors (Basel). 2017 Jan 27;17(2). pii: E244. doi: 10.3390/s17020244.

4.

Application of surface plasmon resonance imaging technique for the detection of single spherical biological submicrometer particles.

Shpacovitch V, Temchura V, Matrosovich M, Hamacher J, Skolnik J, Libuschewski P, Siedhoff D, Weichert F, Marwedel P, Müller H, Überla K, Hergenröder R, Zybin A.

Anal Biochem. 2015 Oct 1;486:62-9. doi: 10.1016/j.ab.2015.06.022. Epub 2015 Jun 18.

PMID:
26095398
5.

Proteinase-activated receptor-2 agonist activates anti-influenza mechanisms and modulates IFNγ-induced antiviral pathways in human neutrophils.

Feld M, Shpacovitch V, Ehrhardt C, Fastrich M, Goerge T, Ludwig S, Steinhoff M.

Biomed Res Int. 2013;2013:879080. doi: 10.1155/2013/879080. Epub 2013 Sep 22.

6.

α-1-Antitrypsin and IFN-γ reduce the severity of IC-mediated vasculitis by regulation of leukocyte recruitment in vivo.

Feld M, Goerge T, Hillgruber C, Steingräber AK, Fastrich M, Shpacovitch V, Steinhoff M.

J Invest Dermatol. 2012 Sep;132(9):2286-95. doi: 10.1038/jid.2012.137. Epub 2012 May 10.

7.

Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease.

Tacke F, Kanig N, En-Nia A, Kaehne T, Eberhardt CS, Shpacovitch V, Trautwein C, Mertens PR.

BMC Cancer. 2011 May 20;11:185. doi: 10.1186/1471-2407-11-185.

8.

Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-γ on human neutrophils and monocytes.

Shpacovitch VM, Feld M, Holzinger D, Kido M, Hollenberg MD, Levi-Schaffer F, Vergnolle N, Ludwig S, Roth J, Luger T, Steinhoff M.

Immunology. 2011 Jul;133(3):329-39. doi: 10.1111/j.1365-2567.2011.03443.x. Epub 2011 Apr 19.

9.

Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.

Seeliger S, Buddenkotte J, Schmidt-Choudhury A, Rosignoli C, Shpacovitch V, von Arnim U, Metze D, Rukwied R, Schmelz M, Paus R, Voegel JJ, Schmidt WE, Steinhoff M.

Am J Pathol. 2010 Nov;177(5):2563-75. doi: 10.2353/ajpath.2010.090941. Epub 2010 Oct 1.

10.

Interferon-γ induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cells.

Feld M, Shpacovitch VM, Fastrich M, Cevikbas F, Steinhoff M.

Exp Dermatol. 2010 Oct;19(10):921-3. doi: 10.1111/j.1600-0625.2010.01147.x.

PMID:
20849534
11.

Agonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infection.

Feld M, Shpacovitch VM, Ehrhardt C, Kerkhoff C, Hollenberg MD, Vergnolle N, Ludwig S, Steinhoff M.

J Immunol. 2008 May 15;180(10):6903-10.

12.

Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils.

Shpacovitch VM, Seeliger S, Huber-Lang M, Balkow S, Feld M, Hollenberg MD, Sarma VJ, Ward PA, Strey A, Gerke V, Sommerhoff CP, Vergnolle N, Steinhoff M.

Exp Dermatol. 2007 Oct;16(10):799-806.

13.

Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.

Goerge T, Barg A, Schnaeker EM, Poppelmann B, Shpacovitch V, Rattenholl A, Maaser C, Luger TA, Steinhoff M, Schneider SW.

Cancer Res. 2006 Aug 1;66(15):7766-74.

14.

Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.

Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, Luger TA, Hollenberg MD.

Endocr Rev. 2005 Feb;26(1):1-43. Review.

PMID:
15689571
15.

Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.

Buddenkotte J, Stroh C, Engels IH, Moormann C, Shpacovitch VM, Seeliger S, Vergnolle N, Vestweber D, Luger TA, Schulze-Osthoff K, Steinhoff M.

J Invest Dermatol. 2005 Jan;124(1):38-45.

16.

Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.

Ständer S, Moormann C, Schumacher M, Buddenkotte J, Artuc M, Shpacovitch V, Brzoska T, Lippert U, Henz BM, Luger TA, Metze D, Steinhoff M.

Exp Dermatol. 2004 Mar;13(3):129-39.

PMID:
14987252
17.

Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells.

Shpacovitch VM, Brzoska T, Buddenkotte J, Stroh C, Sommerhoff CP, Ansel JC, Schulze-Osthoff K, Bunnett NW, Luger TA, Steinhoff M.

J Invest Dermatol. 2002 Feb;118(2):380-5.

Supplemental Content

Loading ...
Support Center